跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
ZONTIVITY
Authorized
STANDARD
ZONTIVITY
XSPIRE PHARMA, LLC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
fa4f9561133a09f4
Company
XSPIRE PHARMA, LLC
Type
Standard
Approval Details
Approval Id
fa4f9561133a09f4
Drug Approval Canada Name
ZONTIVITY
Product Name
ZONTIVITY
Status
Cancelled Pre Market
Status Date
2024-09-13
Din
02454815
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
20:12.18
Atc Original
B01AC26 VORAPAXAR
Atc Name
b 01 ac 26
Aig Number
0158150001
Company Name
XSPIRE PHARMA, LLC
Company Address
Po Box 4006, Brandon, Mississippi, United States, 39047
Company Detail Path
/organization/xspire-pharma-llc-ridgeland-mississippi-united-states
Company Information
Pharmaceutical Company Name
XSPIRE PHARMA, LLC
Country Name
United States
Province Name
Mississippi
City Name
ridgeland,mississippi,country_us
Address
119 Marketridge Dr Ste D
Active Ingredients
VORAPAXAR SULFATE
2.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
fa4f9561133a09f4
Type
Standard
Back to Health Canada Approvals
ZONTIVITY - Health Canada Drug Approval Details